In my talk I'd like to present the recent data published from my team and colleagues of INMI Spallanzani (Rome) in Biomedicines (IF: 5.61) and Frontiers in Microbiology (IF: 5.64) about the very interesting effect of a chemically characterized Euroasian propolis extract in vitro tests. In detail we demonstrated the superiority of the whole phytocomplex compared to single compound in inhibiting overexpression of pro-inflammatory cytokines in LPS-stimulated human PMBC and for its anti Sars-CoV2 effect.
Molecular mechanism will be elucidated.